The Federal Trade Commission said pharmacy benefit managers created a "perverse drug rebate system" that artificially ...

The Federal Trade Commission sued the drug middlemen that health plans use to keep a lid on drug spending, accusing the firms ...

The Federal Trade Commission on Friday filed lawsuits against three prescription drug benefit managers or PBMs over concerns ...

Millions of Americans with diabetes need insulin to survive, yet for many of these vulnerable patients, their insulin drug ...

AIDS Healthcare Foundation (AHF) applauds the U.S. Federal Trade Commission (FTC) for taking decisive action against pharmacy benefit managers (PBMs) that drive up costs for insulin, a product never ...

KFF health policy expert Larry Levitt described the FTC action as a "shot across the bow." "Insulin is an extreme case of PBMs extracting bigger and bigger rebates from drug manufacturers and ...

FTC Sues Prescription Drug Middlemen for Artificially Inflating Insulin Drug Prices – Includes Caremark, Express Scripts, ...

The FTC accused the companies of creating a “perverse” drug rebate system that prioritizes insulin from manufacturers sold at a higher list price even when cheaper versions are available.

According to the FTC, the three largest PBMs — CVS Health’s Caremark, Cigna’s Express Scripts and UnitedHealth’s Optum Rx — used their power to exclude cheaper insulin products from the ...

CVS spokesman David Whitrap said in an emailed statement that the company has worked to make insulin more affordable for Americans and described the FTC as being “simply wrong. “We stand by ...

Caremark, Express Scripts, Optum and their GPOs created a rebate system that boosted PBM profits, FTC alleges.

That artificially raised the list price of insulin, creating what the agency characterized as a "drug rebate system that prioritizes high rebates" from drugmakers, the FTC alleged in announcing ...